Six months old baby with fever and diarrhoea
"acute diarrhea" AND "infant" AND "management"
| Degree | Signs | % Body Weight Lost |
|---|---|---|
| Mild | Slightly dry mucous membranes, normal or mildly decreased skin turgor, still alert | 3-5% |
| Moderate | Dry mucous membranes, reduced skin turgor, sunken eyes/fontanelle, decreased urine output, irritable | 6-9% |
| Severe | Mottled/cool extremities, poor capillary refill (>3 sec), sunken fontanelle, no tears, tachycardia, weak pulse, lethargy | >10% |
Lactose intolerance
"lactose intolerance"[MeSH Terms] AND "diagnosis OR management"
| Type | Description |
|---|---|
| Primary (Adult-type hypolactasia / Lactase Nonpersistence) | Most common worldwide. Physiological decline in lactase activity with age after weaning. This is actually the normal state for ~75% of adults globally. |
| Lactase Persistence | Minority phenotype - lactase activity remains high into adulthood. More common in Northern/Western Europeans and some nomadic African populations. Conferred by variants in the MCM6 gene (13910C>T, 22018G>A) that enhance LCT gene expression. |
| Congenital Lactase Deficiency | Rare autosomal recessive disorder. Severe or total absence of lactase from birth. Presents immediately when newborn is fed breast milk or lactose formula: watery diarrhoea, weight loss, dehydration. Treated by complete lactose removal from diet. |
| Secondary Lactose Malabsorption | Lactase deficiency secondary to small bowel mucosal damage. Causes include gastroenteritis (post-infectious), coeliac disease, Giardia infection, tropical sprue, Crohn's disease, SIBO. Reversible if the underlying condition is treated. |
| Population | Prevalence (%) |
|---|---|
| Asians (US) | ~100 |
| American Indians (Oklahoma) | ~95 |
| Black Americans | ~81 |
| Mexican Americans | ~56 |
| Italians | ~71 |
| Greeks | ~53 |
| White Americans | ~24 |
| Danes | ~3 |
| Dutch | ~0 |
Lactose intolerance in babies with formula feed
"lactose intolerance" AND "infant" AND "formula"
PMID: 38337698
| Feature | Lactose Intolerance (LI) | Cow's Milk Protein Allergy (CMPA) |
|---|---|---|
| Mechanism | Enzyme deficiency (non-immune) | Aberrant immune reaction to casein or β-lactoglobulin |
| Onset | After any lactose load | Variable - IgE-mediated: minutes; non-IgE: hours-days |
| Diarrhoea | Watery, osmotic, acidic stools | Can be watery or bloody/mucousy |
| Vomiting | Present | Present (often more prominent) |
| Bloating/gas | Prominent | Less prominent |
| Blood in stool | Absent | May be present (proctocolitis) |
| Skin symptoms | Absent | Urticaria, eczema (IgE type) |
| Respiratory symptoms | Absent | Wheeze, rhinitis (IgE type) |
| Family history of atopy | Not relevant | Often positive |
| Correct formula | Lactose-free formula | Extensively hydrolysed or amino acid formula |
Misdiagnosis risk is high - confusing the two leads to nutritional harm from inappropriate dietary restriction or unnecessary use of expensive specialised formulas.
| Formula Type | Indication | Notes |
|---|---|---|
| Standard cow's milk formula | Normal infants | Contains lactose (~7 g/100 mL) |
| Lactose-free cow's milk formula | Secondary LI, congenital LI, galactosaemia | Same protein as standard; replaces lactose with glucose syrup/maltodextrin. Suitable for temporary or permanent use. |
| Soy-based formula | Hereditary lactase deficiency, galactosaemia | Lactose-free. Not recommended for preterm infants. Some infants with cow's milk allergy will also react to soy (25-40% cross-reactivity). |
| Extensively hydrolysed protein formula (eHF) | Cow's milk protein allergy, true malabsorption | Lactose-free, protein broken into small peptides. Preferred over soy when allergy is the diagnosis. |
| Amino acid formula (AAF) | Severe CMPA, multiple food protein intolerance | Used when eHF is not tolerated. |
Important: Soy formula is not recommended as a first choice for cow's milk protein allergy because 25-40% of CMPA infants also react to soy protein. Use extensively hydrolysed formula instead for true CMPA.